MeVis Medical Solutions AG (ETR:M3V)
23.20
-0.20 (-0.85%)
May 29, 2026, 5:35 PM CET
ETR:M3V Balance Sheet
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Cash & Short-Term Investments | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Cash Growth | 42.19% | -0.06% | -15.70% | -16.91% | 22.30% | 92.76% |
Accounts Receivable | 1.98 | 1.51 | 2.24 | 2.65 | 4.01 | 2.27 |
Other Receivables | 0.49 | 0.67 | 0.52 | 0.62 | 0.73 | 0.53 |
Receivables | 2.48 | 2.18 | 2.77 | 3.27 | 4.74 | 2.8 |
Other Current Assets | 0.26 | 0.25 | 0.25 | 0.31 | 0.31 | 0.35 |
Total Current Assets | 6.39 | 8.96 | 9.55 | 11.33 | 14.37 | 10.77 |
Property, Plant & Equipment | 0.29 | 0.31 | 0.32 | 0.15 | 0.16 | 0.12 |
Long-Term Investments | - | 0.3 | 0.3 | 0.31 | 0.31 | 0.31 |
Other Intangible Assets | - | - | - | - | 0 | 0 |
Other Long-Term Assets | 0.25 | 0.1 | 0.1 | 0.05 | 0.13 | 0.1 |
Total Assets | 23.16 | 25.89 | 26.48 | 28.05 | 31.2 | 27.53 |
Accounts Payable | 0.08 | 0.14 | 0.09 | 0.08 | 0.19 | 0.24 |
Accrued Expenses | 1.66 | 1.34 | 1.3 | 1.48 | 1.81 | 1.36 |
Current Income Taxes Payable | - | 0 | - | 0.17 | 0.17 | 0.25 |
Other Current Liabilities | - | 0.63 | 0.86 | 1.04 | 0.84 | 0.51 |
Total Current Liabilities | 1.73 | 2.11 | 2.24 | 2.76 | 3.01 | 2.36 |
Long-Term Unearned Revenue | 0.52 | 2.25 | 1.53 | 1.54 | 1.52 | 1.76 |
Pension & Post-Retirement Benefits | 0.26 | 0.23 | 0.25 | 0.27 | 0.54 | 0.48 |
Other Long-Term Liabilities | 2.82 | 3.48 | 4.63 | 5.66 | 8.31 | 5.1 |
Total Liabilities | 5.34 | 8.06 | 8.66 | 10.23 | 13.38 | 9.71 |
Common Stock | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 |
Additional Paid-In Capital | - | - | - | 11.46 | 11.46 | 11.46 |
Retained Earnings | 4.54 | 4.54 | 4.54 | 4.54 | 4.54 | 4.54 |
Comprehensive Income & Other | 11.46 | 11.46 | 11.46 | - | - | - |
Shareholders' Equity | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 |
Total Liabilities & Equity | 23.16 | 25.89 | 26.48 | 28.05 | 31.2 | 27.53 |
Net Cash (Debt) | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Net Cash Growth | 42.19% | -0.06% | -15.70% | -16.91% | 22.30% | 92.76% |
Net Cash Per Share | - | 3.58 | 3.59 | 4.25 | 5.12 | 4.19 |
Filing Date Shares Outstanding | - | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 |
Total Common Shares Outstanding | - | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 |
Working Capital | 4.66 | 6.85 | 7.3 | 8.56 | 11.36 | 8.41 |
Book Value Per Share | - | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |
Tangible Book Value | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 | 17.83 |
Tangible Book Value Per Share | - | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |
Machinery | - | 2.13 | 1.99 | 1.99 | 1.91 | 1.78 |